Your browser doesn't support javascript.
loading
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
Pitt, Jason J; Riester, Markus; Zheng, Yonglan; Yoshimatsu, Toshio F; Sanni, Ayodele; Oluwasola, Olayiwola; Veloso, Artur; Labrot, Emma; Wang, Shengfeng; Odetunde, Abayomi; Ademola, Adeyinka; Okedere, Babajide; Mahan, Scott; Leary, Rebecca; Macomber, Maura; Ajani, Mustapha; Johnson, Ryan S; Fitzgerald, Dominic; Grundstad, A Jason; Tuteja, Jigyasa H; Khramtsova, Galina; Zhang, Jing; Sveen, Elisabeth; Hwang, Bryce; Clayton, Wendy; Nkwodimmah, Chibuzor; Famooto, Bisola; Obasi, Esther; Aderoju, Victor; Oludara, Mobolaji; Omodele, Folusho; Akinyele, Odunayo; Adeoye, Adewunmi; Ogundiran, Temidayo; Babalola, Chinedum; MacIsaac, Kenzie; Popoola, Abiodun; Morrissey, Michael P; Chen, Lin S; Wang, Jiebiao; Olopade, Christopher O; Falusi, Adeyinka G; Winckler, Wendy; Haase, Kerstin; Van Loo, Peter; Obafunwa, John; Papoutsakis, Dimitris; Ojengbede, Oladosu; Weber, Barbara; Ibrahim, Nasiru.
Afiliación
  • Pitt JJ; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
  • Riester M; Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore.
  • Zheng Y; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Yoshimatsu TF; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Sanni A; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Oluwasola O; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Veloso A; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Labrot E; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Wang S; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Odetunde A; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Ademola A; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
  • Okedere B; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Mahan S; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Leary R; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Macomber M; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Ajani M; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Johnson RS; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Fitzgerald D; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Grundstad AJ; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Tuteja JH; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
  • Khramtsova G; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
  • Zhang J; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.
  • Sveen E; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Hwang B; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Clayton W; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Nkwodimmah C; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Famooto B; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Obasi E; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Aderoju V; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Oludara M; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Omodele F; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Akinyele O; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Adeoye A; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Ogundiran T; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Babalola C; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria.
  • MacIsaac K; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Popoola A; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Morrissey MP; Department of Pharmaceutical Chemistry, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Chen LS; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Wang J; Oncology Unit, Department of Radiology, Lagos State University, Ikeja, Lagos, Nigeria.
  • Olopade CO; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Falusi AG; Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA.
  • Winckler W; Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA.
  • Haase K; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
  • Van Loo P; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Obafunwa J; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA.
  • Papoutsakis D; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Ojengbede O; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
  • Weber B; Department of Human Genetics, University of Leuven, Oude Markt 13, Leuven 3000, Belgium.
  • Ibrahim N; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Nat Commun ; 10(1): 288, 2019 01 14.
Article en En | MEDLINE | ID: mdl-30643118
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos